The data valuation layer for preventive personalised health
We develop a technology for health data valuation that is based on Federated Learning, advanced ageing biomarker models, and the principles of behavioural economics.
Unlocking the value of data for health innovation
- Data as an asset class for company valuations
- Fair contribution assessment across data value chains
- Incentives to share data
- User engagement and trust
- Health Economics models augmented by AI
- Standards and best practices for regulatory compliance
All-Parliamentary Group for Longevity
AJAX was selected as one of the three case-studies by the APPG Open Life Data working group. Download the report.
Supported by
